Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes.

Cardiovasc Diabetol · 2018 · PMC5759220 · PMID 29310645

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

Thus, treatment with liraglutide caused the greatest decrease of MDA, PCs and NT-proBNP (p < 0.05), while these changes were of borderline significance after metformin (Table 3 ) after adjusting for HbA1c, weight, BMI and waist circumference.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.